STAT Plus: Nevada fines 21 companies for not providing drug-pricing data




For the first time since requiring drug makers to report pricing data about their diabetes medicines, Nevada officials plan to impose fines totaling more than $17 million on 21 companies for failing to supply information required by a controversial state law.

Earlier this week, the state Department of Health and Human Services wrote each of the drug makers that they face hundreds of thousands of dollars in penalties for not submitting required information, while several others will be fined for failing to meet a deadline. Each drug maker is entitled to an informal dispute resolution before the cases are referred to the state attorney general.

Continue to STAT Plus to read the full story…



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.